Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Italian medtech to gain through pharma decision?:

This article was originally published in Clinica

Executive Summary

The Italian health ministry is calling on the national pharmaceuticals market to cut the prices of medicines, citing evidence that they are "5% more expensive than the European average". The move is set to be welcomed by the rest of the healthcare industry, following high-profile calls for the standards of care to reflect the high cost of running the service (see Clinica No 969, p 7). In last week's correspondence with the pharmaceuticals industry association Farmindustria, health minister Girolamo Sirchia has stated his intention to adopt the "necessary measures" to correct the situation.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT064513

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel